Randomized phase III trial to test the strategy of changing therapy versus maintaining therapy for metastatic breast cancer patients who have elevated circulating tumor cell levels at first follow-up assessment

eagle-i ID

Resource Type

Properties

1. ClinicalTrials.gov url

   http://www.clinicaltrials.gov/ct2/show/NCT00382018?term=S0500&rank=1

2. Additional Topic(s)

   Drug therapy

3. Resource Description

   RATIONALE: When blood levels of tumor cells are high while receiving chemotherapy, it is not yet known whether it is more effective to change chemotherapy regimens at that time or wait until disease progression. PURPOSE: This randomized phase III trial is studying treatment decision making based on blood levels of tumor cells in women with metastatic breast cancer receiving chemotherapy.

4. Contact

   Berenberg, Jeffrey

5. PI

   Berenberg, Jeffrey

6. Topic

   breast cancer

7. Study Population

   Females with histologically confirmed breast cancer.

8. Website(s)

   http://www.cancer.gov/clinicaltrials/featured/trials/swog-s0500

9. Website(s)

   http://www.cancer.gov/clinicaltrials/search/view?cdrid=504319&version=healthprofessional

10. Funded by

    SWOG

11. Phase

    Phase 3 clinical trial

12. Performed by

    Clinical Protocol & Data Management Shared Resource